Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C

Clinical trial NCT00154869 · UNKNOWN

Trial details

NCT number: NCT00154869
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B, Chronic Hepatitis C, Chronic

Start date: 2004-06-01
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.